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Abstract  
Advanced glycation end-products (AGEs) play a pivotal role in macro- and micro- 
vascular diabetic complications. We investigated the mechanism by which 
methylglyoxal (an endogenous generator of AGEs) affects vascular contractility 
using the isolated artery technique. Contractile responses to vasoconstrictors 
phenylephrine (PE), angiotensin II (AngII), vasopressin (VP) and KCl were 
measured in the isolated rat aorta following one-our exposure to methylglyoxal 
(50-200 µM). The perfused rat kidney was employed to confirm the effect of 
methylglyoxal on microvessels. Methylglyoxal-induced changes in cytosolic 
calcium were measured in the smooth muscle layer of the aorta with the calcium-
sensing fluorophore Fluo-4 AM. Methylglyoxal significantly increased maximal 
contraction of the rat aorta to PE, Ang II and VP. Similar results were seen in 
response to the depolarizing vasoconstrictor KCl in macro and micro vessels. The 
methylglyoxal-induced increases in aortic contraction mediated by the agonist and 
KCl were endothelium independent.  Methylglyoxal-induced increases in KCl-
dependent aortic contraction were abolished after the removal of extracellular 
calcium or in the presence of the calcium channel blocker nifedipine. Incubation 
with the antioxidant N-acetyl-L-cysteine (NAC), apocynin (a nonselective NADPH 
oxidase (NOX) inhibitor) or chelerythrine (a protein kinase C (PKC) inhibitor) 
prior to methylglyoxal pre-treatment reversed the methylglyoxal-induced increases 
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in the rat aortic contractility. In conclusion, the formation of AGEs increases 
vasoconstriction of both macro- and micro-vessels by increasing the voltage-
activated calcium entry in vascular smooth muscles in a NOX and PKC dependent 
manner.   
Keywords: methylglyoxal; diabetes mellitus; vascular contraction; rat; aorta.  
1. Introduction: 
Diabetes mellitus (DM) is a disease in which hyperglycemia develops in 
patients as a result of impaired insulin release and/or insulin resistance [1]. The 
World Health Organization registered a staggering 350 million cases of DM 
around the world in 2011 and the number is projected to increase to 440 million by 
the year 2030 [2].    
Diabetic complications are becoming among the fastest growing causes of 
morbidity and mortality worldwide [1].  DM is associated with vascular 
complications and endothelial dysfunction, all of which directly affect vascular 
contractility [1].  High blood sugar levels seen in diabetic patients are believed to 
underlie the generation of AGEs. AGEs are formed in serum and tissues by non-
enzymatic glycation, a reaction of sugars with amino groups of proteins and lipids 
[3]. Raised AGE levels are reported to correlate with diabetic complications, such 
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as nephropathy [4] and retinopathy [5].  AGEs could also be produced from sugar 
derivatives such as glyoxal and methylglyoxal [6]. 
Various studies have reported increased levels of glyoxal and methylglyoxal 
in plasma in diabetic patients [7] and in tissues in the streptozotocin-induced 
diabetic rat model [8]. Further studies demonstrated that methylglyoxal, when 
added to the drinking water, led to development of insulin resistance and 
hypertension in rats [9]. Levels of methylglyoxal also increased with ageing in 
spontaneously hypertensive rats [10].  
However, only few studies investigated the effect of methylglyoxal on 
vascular reactivity.  Pre-treatment of cultured rat aortic rings with methylglyoxal 
for 24 hours reduced endothelium-dependent relaxation due to reduction of 
expression and function of endothelial nitric oxide synthase [11].  Conversely, a 
short pre-treatment of rat vasculature with methylglyoxal either increased 
angiotensin II (Ang II) mediated contraction in the endothelial-dependent manner 
[12] or inhibited noradrenaline-mediated contraction in endothelium-independent 
fashion [13]. We recently reported that methylglyoxal reduced acetylcholine-
mediated relaxation of the rat aorta precontracted with phenylephrine, but on the 
other hand, augmented phenylephrine-induced contraction  [14]. Mechanisms of 
the methylglyoxal-induced increase in tension were not yet characterized. 
Therefore, this study aimed to investigate the effect of methylglyoxal on 
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contraction of isolated rat aorta in response to various agonists and elucidate the 
mechanistic basis of augmented vascular reactivity. The effects of methylglyoxal 
on microvascular reactivity in the perfused rat kidney preparation were also 
assessed in vitro.  The outcome of this study provides a better understanding of the 
importance of AGEs in vascular diabetic complications. 
Materials and methods: 
2.1 Drugs and chemicals: 
Vasopressin (20 units/mL) was manufactured by Swiss Parentrals PVT.  
Nifedipine, N-acetyl-L-cysteine (NAC) and chelerythrine were purchased from 
LKT Laboratories. Methylglyoxal, potassium chloride (KCl), angiotensin II (Ang 
II), phenylephrine and apocynin were purchased from Sigma–Aldrich, Dorset, UK. 
Fluo-4 AM was purchased from Thermo Fischer Scientific, UK. Ethylene glycol-
bis(-aminoethyl ether)-N,N,N’,N’-tetraacetic acid (EGTA) was purchased from 
Hach company (Loveland, USA).  Chelerythrine and apocynin were dissolved in 
dimethylsulfoxide (DMSO) and stored in aliquots at -20°C. All other drugs were   
dissolved in pure de-ionized water. Final DMSO concentration did not exceeded 
0.1% and had no significant effect on aortic contraction (our preliminary data and 
previously published studies [14]). 
2.2 Experimental animals: 
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Male Wistar rats (180-200 g) from the animal house facility at the King Abdul-
Aziz University-Research Center were killed by decapitation. The descending 
aorta was carefully removed, placed in a cold Krebs–Henseleit buffer (KHB), 
cleaned of surrounding fat and connective tissue and then cut into ~3 mm rings in 
length.  
2.3 Research design: 
The research methodologies were in accordance with the Regulations of Research 
Bioethics on the Living Creatures of the National Committee of Biomedical Ethics, 
Kingdom of Saudi Arabia.  The protocol was approved by the Research Ethics 
Committee, Faculty of Pharmacy, King Abdulaziz University (Reference No. 
1438-110). 
2.3.1 Macrovascular reactivity: 
Isometric tension measurements from isolated thoracic aortae were performed 
using the organ bath technique as previously described [14].  Briefly, aortic rings 
were suspended in an organ bath filled with KHB containing (in mM): NaCl 118.1, 
KCl 4.7, CaCl2 2.5; MgSO4 1.2, NaHCO3 25.0, KH2PO4 1.2, glucose 11; pH=7.4; 
at 37oC and bubbled with 95% O2 / 5% CO2. Vessels were kept under constant 
1500 mg tension in the presence or absence of the AGE generating compound 
methylglyoxal. Aortic rings isolated from the same rat were incubated for 1 hour in 
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KHB (control) or in different concentrations of methylglyoxal (50, 100 or 200 
μM). Cumulative concentration-response curve (CRC) to PE (10-8-10-5 M), Ang II 
(10-9-10-6 M), vasopressin (10-10-10-7 M) or KCl (10-100 mM) were measured in 
the control and methylglyoxal-treated preparations. Agonists (PE, ANG II and 
vasopressin) were added in semi-logarithmic and KCl in 10 mM increments. To 
assess mechanisms underlying methylglyoxal-mediated effects, experiments were 
carried out in a nominally Ca2+-free KHB (with 1 mM EGTA), and, separately, in 
the presence of 100 µM nifedipine, 1 mM NAC, 10 µM apocynin or 10 µM 
chelerythrine using KCl as a vasoconstrictor. All inhibitors were added 30 min 
prior to methylglyoxal pre-treatment. The responses were recorded by an isometric 
force transducer (MLT202) connected to a data acquisition system (Powerlab® 
8/30) running Labchart Pro® 8.1.5 software (AD Instruments, Australia). Where 
stated, the endothelium was removed by gently rubbing the vessel lumen with a 
thin smooth pin and successful removal was verified as the lack of response to 1 
µM acetylcholine.  
2.3.2 Microvascular studies: 
The effect of methylglyoxal on microvasculature was evaluated in an isolated 
perfused left kidney of the rat as described previously [15].  Briefly, after the 
animal was killed by decapitation and the left kidney was accessed via an incision 
in the abdomen. The left renal artery was exposed, cleaned of surrounding adipose 
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tissue and cannulated with an 18-gauge needle through an incision in the aorta. The 
cannula was stabilized with ligature placed around the renal artery. The kidney was 
flushed with 5 mL of heparinized saline solution (100 U/mL heparin), excised, 
transferred into a glass chamber and then perfused with KHB (37oC, 95% +O2, 5% 
CO2) for 30 minutes before starting the experiment.  A peristaltic pump 
(Masterflex®, Colepalmer, Jubail, Saudi Arabia) was used to maintain a flow rate 
of 3 mL/min and the effluent from the veins was allowed free drainage. Changes in 
perfusion pressure as the measure of microvascular resistance were measured using 
a pressure transducer connected to a Power Lab Data system (Gould P23ID, USA) 
and analyzed using Labchart Pro® 8.1.5 software (AD Instruments, Australia). An 
isolated kidney was perfused with or without methylglyoxal (100 µM) for 1 h 
followed by perfusion with KCl (10-100 mM). 
2.3.3 Intracellular calcium monitoring: 
Intracellular calcium was monitored in the aortic smooth muscle layer using the 
fluorescence probe Fluo-4 AM as previously described with some modifications 
[16]. Isolated aortic rings (~ 3 mm length) were cut open longitudinally and the 
endothelium layer was gently rubbed off and incubated in 1.5 mL conical plastic 
tubes containing KHB without (control) or with methylglyoxal (100 µM) for 1 
hour at 37ºC. Following the incubation, aortic preparations were carefully 
transferred to different conical plastic tubes with fresh KHB containing Fluo-4 AM 
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(0.2 µM) and incubated for 15 minutes at 37ºC. Pieces of aorta were transferred to 
conical plastic tubes containing dye-free KHB for 5 min at 37ºC.  Aortic tissues 
with the smooth muscle layer facing upwards were placed in a 96-well black plate, 
secured in place with small clear plastic rings, and 200 µL KHB was added to each 
well. Calcium influx in aortic smooth muscles was stimulated by KCl (80 mM) and 
fluorescence intensity (λex=480 nm, λem=506 nm) was measured every minute for 
10 min using a SpectraMax® M3 monochromator plate reader (Molecular Devices, 
California, USA). Fluorescence was also measured in the presence of 
methylglyoxal and nifedipine (100 µM). Changes in intracellular calcium levels 
were expressed as Fluo-4 fluorescence intensity in arbitrary units.  
2.4 Statistical analysis: 
Values were expressed as mean ± standard error of the mean (SEM) with n 
representing the number of rats with 6-8 animals typically used in each 
experimental protocol.  The difference between the groups was analyzed by the 
two-way analysis of variance (ANOVA) followed by Bonferroni post-hoc test.  
Statistical significance was determined as p < 0.05. Data were analyzed using 
Prism 5 software (Graphpad v5, CA, USA).  
2. Results: 
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3.1 The effect of methylglyoxal on receptor-mediated contraction of the 
isolated rat aorta: 
Figure 1A compares the effect of a one-hour incubation with methylglyoxal (50, 
100 or 200 µM) on cumulative CRC to PE in isolated aortic rings with intact 
endothelium.  Methylglyoxal enhanced PE-induced contraction at all 
concentrations, however, the effect was significantly different from the control at 
PE concentrations between 1x10-6 and 1x10-5 M after pre-treatment with 200 µM. 
100 µM methylglyoxal also significantly increased contraction at 1x10-5 M of PE 
(p<0.05, Fig. 1A).  
Notably, significant enhancement of contraction to PE (between 3x10-7 and 
1x10-5 M) was also observed in endothelium-denuded aortic preparations pre-
treated with 200 µM of methylglyoxal (p<0.05, Fig. 1B).  
Qualitatively similar effects of methylglyoxal pre-treatment on contractions 
induced Ang II (Fig. 1C) and vasopressin (Fig. 1D) were also observed in 
endothelium-denuded rat aorta vessels. Although the responses in lower 
concentrations of methylglyoxal varied, pre-treatment with 200 µM caused 
significant potentiation of contraction to Ang II (at 1x10-6 M, p<0.05, Fig. 1C) and 
vasopressin (between 3x10-8 and 1x10−7 M, p<0.05, Fig. 1D) when compared to 
respective controls. 
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3.2 The effect of methylglyoxal on KCl-mediated responses in the rat aorta 
and in isolated perfused rat kidney:  
To assess the role the voltage-activated calcium entry may play in methylglyoxal-
mediated increases of agonist-induced contractions, cumulative CRCs to a 
depolarizing vasoconstrictor KCl were examined in endothelium-intact (Fig. 2A) 
and endothelium-denuded (Fig. 2B) aortic preparations, pre-treated with 50, 100 or 
200 µM of methylglyoxal.  
In endothelium-intact aortic rings, 50 µM methylglyoxal caused a marked 
increase in KCl-induced response that was significantly different at concentrations 
between 80 and 100 mM compared to the control (p<0.05). In higher 
concentrations of methylglyoxal, KCl-induced contraction tended to be reduced 
compared to that at 50 µM (Fig. 2A). 
In endothelium-denuded vessels, contraction to KCl increased in all 
concentrations of methylglyoxal compared to the control with most significant 
differences observed between 30 and 100 mM KCl after pre-treatment with 100 
µM methylglyoxal (p<0.05, Fig. 2B).  
To assess if microvessels were affected by methylglyoxal in a similar 
fashion as conduit arteries, the isolated rat left kidney was perfused with 50 or 100 
µM of methylglyoxal for 1 hour followed by perfusion with increasing 
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concentrations of KCl. Figure 2C shows that perfusion pressure was progressively 
increased after pre-treatment with methylglyoxal being significantly different at 80 
and 100 mM KCl in 100 µM of methylglyoxal compared to the control kidney 
(p<0.05, Fig. 2C).   
3.3 Role of extracellular calcium and voltage-activated calcium entry in 
methylglyoxal-mediated increases in KCl contraction: 
To elucidate the role of extracellular calcium in methylglyoxal-mediated increase 
of KCl-induced contraction, CRCs to KCl were examined in endothelium-denuded 
aortic rings bathed in Ca2+-free KHB. In this condition, KCl contractions were 
markedly reduced (Fig. 3A) compared to normal KHB (Fig. 2B) with no 
significant differences seen in any concentration of methylglyoxal when compared 
to the control group (Fig. 3A).   
Similar effects on KCl-induced contraction were seen in normal KHB in the 
presence of the L-type Ca2+ channel blocker nifedipine (Fig. 3B).  Nifedipine 
significantly attenuated KCl-induced contraction between 70 and 100 mM 
following pre-treatment with 100 µM methylglyoxal (p<0.05, Fig. 3B). 
 To determine the effect on free cytosolic calcium, endothelium denuded 
aortic rings loaded with Fluo-4 (see Methods for details) were pre-incubated with 
methylglyoxal or methylglyoxal and nifedipine (all at 100 µM) and compared to 
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the control. All preparations were stimulated with 80 mM KCl (Fig. 3C).  
Methylglyoxal caused a significant increase in Fluo-4 fluorescence 2 min after 
stimulation with KCl. This effect was abolished by nifedipine (Fig. 3C). 
 
3.4 The effect of NOX and PKC inhibitors on methylglyoxal-mediated 
increases in KCl-induced contraction: 
To elucidate intracellular pathways which contribute to methylglyoxal-induced 
effects on KCl contraction, endothelium-denuded rat aortic rings were pre-treated 
with apocynin (a broad-spectrum NOX inhibitor, 10 µM), chelerythrine (a 
selective PKC inhibitor, 10 µM) or N-acetyl-L-cysteine (NAC) (an antioxidant, 1 
mM) for 30 min prior a one-hour pre-treatment with 100 µM methylglyoxal 
followed by CRC to KCl (Fig. 4).  
Apocynin, while having no effect alone, abolished the methylglyoxal-
mediated increase in KCl contraction (Fig. 4A). Although chelerythine alone 
significantly attenuated KCl-induced contraction, it also completely blocked the 
effect of methylglyoxal to a similar degree as the inhibitor alone (Fig. 4B).  
Likewise, the antioxidant NAC completely blocked the methylglyoxal-mediated 
increase in KCl contraction, although, when added alone, the antioxidant tends to 
enhance KCl responses albeit non-significantly (Fig. 4C).  
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4. Discussion: 
Our study aimed at determining the mechanism by which AGEs may cause an 
increase in vasoconstriction responses, which is a key factor in diabetic vascular 
complications.  We used methylglyoxal, one of reactive intracellular dicarbonyls, 
produced as a consequence of intracellular hyperglycaemia, which are thought to 
be a major source for formation of AGEs [17]. The main findings of this study 
show that methylglyoxal: i) increased agonist- and depolarization-induced 
contractions of large conduit arteries (the aorta) and microvessels (perfused 
kidney); ii) acted mainly in endothelium-independent fashion; iii) its effects were 
markedly dependent on depolarization-mediated voltage-activated calcium influx, 
and iv) its effects required activation of NOX and PKC.  
Only two focused reports by Mukohda and colleagues directly evaluated the 
effect of methylglyoxal on agonist-induced contractions in large arteries. One 
study showed that exposure of the rat carotid artery methylglyoxal (420 µM) for 30 
min increased Ang II-mediated contraction in the endothelium-dependent manner 
[12]. In another report, a 30 min pre-treatment with methylglyoxal inhibited 
noradrenaline-induced contraction in the endothelium-denuded aorta and superior 
mesenteric artery of the rat. The effect of methylglyoxal in the aorta was 
concentration independent (42-420 µM) with only 420 µM used in the mesenteric 
artery [13]. Above mentioned reports are in contrast to our findings where a 
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significant methylglyoxal-mediated potentiation of contraction of the rat aorta to 
both the 1-adrenoceptor agonist phenylephrine and Ang II which were 
endothelium-independent for both agonists (Fig. 1B and 1C, respectively), as well 
as to vasopressin, an agonist that was not previously tested (Fig. 1D). Furthermore, 
phenylephrine-induced contraction tends to progressively increase with exposure 
to increasing concentrations of methylglyoxal (50-200 µM) in both endothelium-
intact (Fig. 1A) and endothelium-denuded (Fig. 1B) vessels. The apparent 
disconcert between our findings and previous studies is likely to be due to the 
difference mainly in the duration of pre-treatment to methylglyoxal (1 hour pre-
treatment used in this study vs 30 min in previous reports) and perhaps exposure to 
lower concentrations of methylglyoxal in our experiments.   
Although tissue specificity cannot be entirely excluded, the ability of 
methylglyoxal to enhance contraction of endothelium-denuded aortic rings to three 
different agonists, phenylephrine, Ang II and vasopressin, strongly supports the 
presence of a common mechanism activated after a one-hour pretreatment on 
smooth muscle cells.  Two principle mechanisms could be considered. One is via 
direct activation of Gq/11 coupled of 1-adrenoceptors, angiotensin AT1 receptors 
[18] and vasopressin V1 receptors [19] on smooth muscles by respective agonists 
triggering inositol-1,4,5-trisphosphate (IP3)-mediated intracellular calcium release. 
Another possibility could be an increased voltage-dependent calcium influx 
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triggered by membrane depolarization. The ability of agonists to depolarize smooth 
muscle cells via activation of non-selective cation channels, calcium-activated 
chloride channels or by activating voltage-activated calcium channels directly is 
well-recognized [20].  
The important role of the voltage-activated Ca2+ influx in methylglyoxal-
mediated increases in vascular reactivity is supported by comparing CRCs to KCl 
in endothelium-intact and endothelium-denuded aortic rings before and after pre-
treatment with methylglyoxal (Fig. 2A,B). The inhibitory effect of extracellular 
calcium removal and a complete block of the methylglyoxal-mediated increase in 
KCl-induced contraction and intracellular calcium concentration in rat aorta by the 
voltage-activated calcium channel blocker nifedipine (Fig. 3) are also consistent 
with this conclusion.   
Notably, our findings differ from the observation made by Mukohda et al. 
(2009) who found no differences in KCl contraction in endothelium-denuded aortic 
preparations after a shorter 30 min pre-treatment with similar concentrations of 
methylglyoxal [13]. However, in cultured arteries exposed to low concentrations of 
methylglyoxal for 3 days KCl contraction was inhibited [21], supporting our 
conclusion that methylglyoxal effects are both time and concentration dependent.  
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Interestingly, KCl-induced contraction was reduced following pre-treatment 
with a higher 200 µM methylglyoxal in both endothelium-intact and endothelium-
denuded preparations when compared with 50 and 100 µM (Fig 2, A and B). This 
reduction is unlikely due to activation of K+ channels in smooth muscle cells which 
would be blocked by high KCl. Hence, the mechanism is different from activation 
of large-conductance Ca2+-activated K+ channels that attenuated noradrenaline-
mediated contraction reported previously [15]. It is possible that high 
concentrations of methylglyoxal would inhibit nifedipine-sensitive voltage-
activated calcium channels, as was demonstrated with phenylglyoxal in mouse 
cerebellum neurons [27], and, in this case, it may contribute to suppression of 
agonist-mediated contraction reported previously by Mukohda and colleagues.  
The ability of methylglyoxal to potentiate KCl-induced vasoconstriction in 
isolated perfused kidney (Fig. 2C) in a similar manner as in large conduit vessels 
(Fig. 2A) could indicate the existence of common mechanisms in methylglyoxal-
mediated effects that might be important in blood pressure control and renal 
complication in diabetes.   
To elucidate downstream signaling pathways involved in methylglyoxal-
mediated effects on KCl contraction the broad spectrum NOX inhibitor apocynin 
and selective inhibitor of PKC chelerythrine were used in endothelium-denuded 
aortic rings (Fig. 4,A and B). Both inhibitors completely blocked the 
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methylglyoxal-mediated increases in KCl contraction. Correspondingly, reduction 
of oxidative stress with the antioxidant NAC also inhibited the effect of 
methylglyoxal (Fig. 4C). The link between increased oxidative stress, 
hyperglycaemia and AGEs has been well recognized [22]. Previous studies showed 
that NOX inhibitors, including apocynin, prevented the endothelium-dependent 
increase in Ang II responses during short-term exposure to methylglyoxal [12], 
while NAC inhibited decreases in noradrenaline-induced contraction associated 
with increased NOX activity induced by a 3-day exposure to methylglyoxal in 
cultured endothelium-denuded mesenteric arteries [21]. Our data demonstrate that 
a one-hour exposure to methylglyoxal increases nifedipine-sensitive voltage-
activated calcium entry in aortic smooth muscle cells via activation of NOX and 
PKC. Although detailed mechanisms including specific NOX and PKC isoforms 
involved will require a separate study, calcium-sensitive isoforms of PKC are 
likely to be involved in the absence of agonists. Indeed, NOX mediated activation 
of the Ca2+-sensitive PKC led to increased L-type calcium channel activity in 
vascular smooth muscle cells [23].  
In conclusion, we have described a novel effect of methylglyoxal on vascular 
reactivity demonstrating that methylglyoxal enhances vascular contractility in both 
conduit and resistance vessels in response to a range of vasoconstricting agents. 
This effect resided within vascular smooth muscle cells and is likely to be 
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mediated by an increase in the nifedipine-sensitive voltage-activated Ca2+ influx 
mediated by increased NOX and PKC activity.   
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Figure Legends: 
Figure 1: Effect of methylglyoxal (MG) on agonist-induced contraction of the 
rat aorta in the presence and absence of endothelium. (A) and (B) show the 
effect of phenylephrine (PE) in endothelium-intact (A) and endothelium-denuded 
vessels (B), (C) and (D) show the effect of angiotensin II (Ang II) and vasopressin 
(VP), respectively, in endothelium-denuded preparations following one-hour pre-
incubation with different concentrations of methylglyoxal as indicated.  Values are 
shown as mean  SEM, *p < 0.05, compared to control, n= 7.  
Figure 2: Effect of methylglyoxal on KCl-mediated responses in endothelium-
intact and endothelium-denuded rat aortic rings (A, B) and in the isolated 
perfused rat kidney (C).  (A) and (B) compares KCl responses in endothelium-
intact and endothelium-denuded aortic preparations, respectively, after one-hour 
exposure to different concentrations of methylglyoxal (MG) as indicated by the 
symbols. Note difference in scale in (A) and (B). (C) shows the changes in 
perfusion pressure to KCl following one-hour pre-treatment of the isolated rat 
kidney with 50 and 100 µM of methylglyoxal. Values are expressed as mean  
SEM, *p < 0.05, compared to control, n = 6-8.  
25 
 
 
Figure 3: The role of extracellular calcium entry in methylglyoxal-mediated 
enhancement of KCl-induced contraction in the endothelium denuded rat 
aorta.  Concentration-response curves to KCl recorded in the presence of different 
concentrations of methylglyoxal (MG) (50,100 or 200 µM) in Ca2+-free KHB (+1 
mM EGTA) (A) and in the presence of nifedipine (100 µM) (B).  Time-dependent 
changes in Fluo-4 fluorescence intensity (expressed in arbitrary units (a.u.)) in rat 
aortic smooth muscles stimulated with 80 mM KCl (added at 0 min) under control 
condition and after pre-treatment with 100 µM MG or MG + nifedipine (both at 
100 µM) (C). Values are expressed as mean  SEM, *p < 0.05, compared to 
control, n = 7. 
 
Figure 4: Effects of apocynin, chelerythrine and N-acetyl-L-cysteine (NAC) on 
methylglyoxal-induced increases in KCl contraction in the endothelium-
denuded rat aorta. Comparison of concentration-response curves to KCl recorded 
in the presence of 10 µM apocynin (Apo) (A), 10 µM chelerythrine (Chel) (B) and 
1 mM NAC (C) in the absence and following the pre-treatment with 100 µM 
methylglyoxal (MG) (blue tringles). Control (in the absence of the inhibitors or 
MG) and the effect of MG alone (black circles) are shown for comparison. Values 
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are expressed as mean  SEM, n=8. * and # indicate p < 0.05 compared to the 
control (*) and the MG-treated (#) preparations. 
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